Evidence map›Paper›PMID 37673118›Full record

ArticleNature2023

Complete human day 14 post-implantation embryo models from naive ES cells.

Bernardo Oldak, Emilie Wildschutz, Vladyslav Bondarenko, Mehmet-Yunus Comar, Cheng Zhao, Alejandro Aguilera-Castrejon, Shadi Tarazi, Sergey Viukov, Thi Xuan Ai Pham, Shahd Ashouokhi and 17 more

Open access · hybridAbstract read
In one paragraph

Article in Nature, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 137 papers.

0numbers the graph read from it
0cells of the map it votes in
137citing papers in PubMed
27.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

137 citing papers in PubMed, 177 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article

77 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors at 3 institutions in 4 countries.

Bernardo Oldak *Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Emilie Wildschutz *Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Vladyslav Bondarenko *Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Mehmet-Yunus ComarDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Cheng ZhaoDepartment of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
Alejandro Aguilera-CastrejonDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0002-1339-7778
Shadi TaraziDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0002-4121-4289
Sergey ViukovDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Thi Xuan Ai PhamDepartment of Development and Regeneration, Leuven Stem Cell Institute, Leuven Institute for Single-cell Omics (LISCO), KU Leuven-University of Leuven, Leuven, Belgium.
Shahd AshouokhiDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Dmitry LokshtanovDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Francesco RoncatoDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Eitan ArielDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Max RoseDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Nir LivnatDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Tom ShaniDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0002-4878-2174
Carine JoubranDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Roni CohenDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Yoseph AddadiDepartment of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0001-9827-0436
Muriel ChemlaDepartment of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
Merav KedmiDepartment of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
Hadas Keren-ShaulDepartment of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
Vincent PasqueDepartment of Development and Regeneration, Leuven Stem Cell Institute, Leuven Institute for Single-cell Omics (LISCO), KU Leuven-University of Leuven, Leuven, Belgium.
Sophie PetropoulosDepartment of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
Fredrik LannerDepartment of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-2771-7445
Noa NovershternDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0002-2244-6877
Jacob H HannaDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel. jacob.hanna@weizmann.ac.il.ORCID 0000-0003-2042-9974
Weizmann Institute of Science · ILKarolinska University Hospital · SEKU Leuven · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ability to study human post-implantation development remains limited owing to ethical and technical challenges associated with intrauterine development after implantation

Indexed as

Embryo ImplantationEmbryo, MammalianEmbryonic DevelopmentHuman Embryonic Stem CellsFertilizationGastrulationGerm LayersGiant CellsHumansTrophoblastsYolk Sac

Identifiers

PMID37673118
PMCPMC10584686
OpenAlexW4386492442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.